quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:16:46·79d
INSIDERFiling
Senti Biosciences Inc. logo

CEO Lu Timothy K covered exercise/tax liability with 4,191 shares, decreasing direct ownership by 0.58% to 720,249 units (SEC Form 4)

SNTI· Senti Biosciences Inc.
Health Care
Original source

Companies

  • SNTI
    Senti Biosciences Inc.
    Health Care

Recent analyst ratings

  • Oct 14UpdateH.C. Wainwright$12.00
  • Jun 6UpdateLaidlaw$5.00
  • Oct 7UpdateMorgan Stanley$7.50

Related

  • SEC2h
    SEC Form POS AM filed by Senti Biosciences Inc.
  • SEC7d
    Amendment: SEC Form SCHEDULE 13D/A filed by Senti Biosciences Inc.
  • PR11d
    Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
  • SEC22d
    Senti Biosciences Inc. filed SEC Form 8-K: Other Events
  • PR23d
    Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies
  • SEC23d
    Amendment: SEC Form SCHEDULE 13D/A filed by Senti Biosciences Inc.
  • SEC28d
    SEC Form 10-K filed by Senti Biosciences Inc.
  • SEC28d
    Senti Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022